Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART-3: Bazedoxifene/Conjugated Estrogens for Vaginal Atrophy
NCT00238732Phase 3Completed
- Sponsor
- Pfizer
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bazedoxifene, conjugated estrogens in vulvovaginal atrophy (VVA), sponsored by Pfizer. Started Oct 2005; status: completed.
02
Drugs
bazedoxifeneconjugated estrogens
03
Conditions
vulvovaginal atrophy (VVA)
Beyond the preview
Go deeper on NCT00238732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00238732.